File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster

TitleSingle-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster
Authors
Hung, IFNPoland, GA
Issue Date2021
PublisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/lancet
Citation
The Lancet, 2021, v. 397 n. 10277, p. 854-855 How to Cite?
DOI: http://dx.doi.org/10.1016/S0140-6736(21)00528-6
Persistent Identifierhttp://hdl.handle.net/10722/306505
ISSN
0140-6736
2021 Impact Factor: 202.731
2020 SCImago Journal Rankings: 13.103
PubMed Central ID
PMC8086170

 

DC FieldValueLanguage
dc.contributor.authorHung, IFN-
dc.contributor.authorPoland, GA-
dc.date.accessioned2021-10-22T07:35:34Z-
dc.date.available2021-10-22T07:35:34Z-
dc.date.issued2021-
dc.identifier.citationThe Lancet, 2021, v. 397 n. 10277, p. 854-855-
dc.identifier.issn0140-6736-
dc.identifier.urihttp://hdl.handle.net/10722/306505-
dc.languageeng-
dc.publisherThe Lancet Publishing Group. The Journal's web site is located at http://www.elsevier.com/locate/lancet-
dc.relation.ispartofThe Lancet-
dc.titleSingle-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster-
dc.typeArticle-
dc.identifier.emailHung, IFN: ivanhung@hkucc.hku.hk-
dc.identifier.authorityHung, IFN=rp00508-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1016/S0140-6736(21)00528-6-
dc.identifier.pmid33676614-
dc.identifier.pmcidPMC8086170-
dc.identifier.scopuseid_2-s2.0-85101873371-
dc.identifier.hkuros328690-
dc.identifier.volume397-
dc.identifier.issue10277-
dc.identifier.spage854-
dc.identifier.epage855-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats